Hide
Show all
Email this article IN SILICO SCREENING OF SOME COMMERCIALLY AVAILABLE ALKALOIDS AGAINST ANGIOTENSIN CONVERTING ENZYME USING LAMARCKIAN GENETIC ALGORITHM
Abstract
Alkaloids are the dynamic components that may show an essential part in preventing the hypertension. Captopril, a known angiotensin converting enzyme inhibitor was considered as the standard. An in silico screening study was performed to detect the inhibitory potential of the alkaloids against angiotensin converting enzyme by using the Autodock 4.2 software. The alkaloids ajmaline, atropine, caffeine and emetine were selected for the present study. The results revealed that all the selected alkaloids exhibited binding energy ranging between -9.75 kcal/mol to -4.98 kcal/mol when compared with the standard (-5.38 kcal/mol). Inhibition constant (77.38 nM to 225.41 µM) and Intermolecular energy (-11.84 kcal/mol to -6.17 kcal/mol) of the alkaloids also concur with the binding energy. Hence, these alkaloids can be further scrutinized for in vivo studies and thereby it may act as potential chemical entities for the prevention and treatment of hypertension.
Keywords
References
Cosconati, S.; Forli, S.; Perryman, A.L.; Harris, R.; Goodsell, D.S.; Olson, A.J. Virtual screening with AutoDock: Theory and practice. Expert Opinion on Drug Discovery 5 (2010) 597-607.
Cushnie, T.P.; Cushnie, B.; Lamb, A.J. Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities. International Journal of Antimicrobial Agents 44(5) (2014) 377-386.
Davies, D.L.; Shepherd, M. Reserpine in the Treatment of Anxious and Depressed Patients. The Lancet 269 (1955) 117–120.
Folkow, B. Physiological aspects of primary hypertension. Physiological Reviews 62(2) (1982) 347-504.
Goodsell, D.S.; Morris, G.M.; Olson, A.J. Automated docking of flexible ligands: Applications of Autodock. Journal of Molecular Recognition 9 (1996) 1-5.
Gschwend, D.A.; Good, A.C.; Kuntz, I.D. Molecular docking towards drug discovery. Journal of Molecular Recognition 9 (1996) 175-186.
Grover, A.; Shandilya, A.; Agrawal, V.; Bisaria, V.S.; Sundar, D. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. Journal of Biomolecular Structure and Dynamics 29(4) (2012) 651-662.
Hamulakova, S.; Janovec, L.; Soukup, O.; Jun, D.; Kuca, K. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids. International Journal of Biological Macromolecules 104 (2017) 333-338.
Imig, J.D. ACE inhibition and Bradykinin-mediated renal vascular responses: EDHF involvement. Hypertension 43(3) (2004) 533-535.
Irwin, J.J.; Shoichet, B.K. ZINC - a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling 45 (2005) 177-182.
John, R.L. Amaryllidaceae, muscarine, imidazole, oxazole, thiazole and peptide alkaloids, and other miscellaneous alkaloids. Natural Product Reports 17(1) (2000) 57-84.
Kittakoop, P.; Mahidol, C.; Ruchirawat, S. Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Current Topics in Medicinal Chemistry 14(2) (2014) 239-252.
Lazartigues, E.; Feng, Y.; Lavoie, J.L. The two faces of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Current Pharmaceutical Design 13(12) (2007) 1231-1245.
Madeswaran, A.; Asokkumar, K. Evaluation of inhibitory affinity potential of the alkaloids against crystal structure of human angiotensin-converting enzyme using Lamarckian genetic algorithm. Oriental Pharmacy and Experimental Medicine 15(3) (2015) 183-189.
Madeswaran, A.; Umamaheswari, M.; Asokkumar, K.; Sivashanmugam, A.; Subhadradevi, V.; Jagannath P. Computational drug discovery of potential TAU protein kinase I inhibitors using in silico docking studies. Bangladesh Journal of Pharmacology 8 (2013) 131-135.
Madeswaran, A.; Umamaheswari, M.; Asokkumar, K.; Sivashanmugam, T.; Subhadradevi, V.; Jagannath, P. In silico docking studies of phosphodiesterase inhibitory activity of commercially available flavonoids. Oriental Pharmacy and Experimental Medicine 12 (2012) 301-306.
Mitrasinovic, P.M. Advances in the structure-based design of the influenza-A neuraminidase inhibitors. Current drug targets 11 (2010) 315-326.
Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry 30 (2009) 2785-2791.
Norris, R.; Casey, F.; FitzGerald, R.; Shields, D.C.; Mooney, C. Predictive modelling of angiotensin converting enzyme inhibitory dipeptides. Food Chemistry 133(4) (2012) 1349-1354.
Sehgal, A.S.; Mannan, S.; Kanwal, S.; Naveed, I.; Mir, A. Adaptive evolution and elucidating the potential inhibitor against schizophrenia to target DAOA (G72) isoforms. Drug Design, Development and Therapy 9 (2015) 3471-3480.
Sever, P.S.; Messerli. F.H. Hypertension management 2011: Optimal combination therapy. European Heart Journal 32(20) (2011) 2499-2506.
Singer, D.R.; Kite, A. Management of hypertension in peripheral arterial disease: does the choice of drugs matter? European Journal of Vascular and Endovascular Surgery 35(6) (2008) 701-708.
Thomsen R.; Christensen MH. MolDock: a new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry 49(11) (2006) 3315-3321.
Wolber, G.; Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling 45(1) (2005) 160-169.
Wong, T.Y.; Mitchell, P. The eye in hypertension. Lancet 369 (9559) (2007) 425-435.
Zhang, R.; Xu, X.; Chen, T.; Li, L.; Rao, P. An assay for angiotensin-converting enzyme using capillary zone electrophoresis. Analytical Biochemistry 280(2) (2000) 286-290.
DOI: http://dx.doi.org/10.5281/zenodo.3353473
Refbacks
- There are currently no refbacks.
Copyright (c) 2019 Arumugam Madeswaran
_________________________________________________________________________________________________________________________
All open access articles published in AJNP are distributed under the terms of the Creative Commons Attribution- 4.0 International License
The research works published in this journal are free to be accessed. They can be shared (copied and redistributed in any medium or format) and\or adapted (remixed, transformed, and built upon the material for any purpose, commercially and\or not commercially) under the following terms: attribution (appropriate credit must be given indicating original authors, research work name and publication name mentioning if changes were made) and without adding additional restrictions (without restricting others from doing anything the actual license permits). Authors retain the full copyright of their published research works and cannot revoke these freedoms as long as the license terms are followed.